These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 31284000

  • 1. Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity.
    Kamau F, Strijdom H, Mwangi P, Blackhurst D, Imperial E, Salie R.
    Vascul Pharmacol; 2019 Oct; 121():106577. PubMed ID: 31284000
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A, Patel V, Kshirsagar S, Patel MS, Savsani H, Jain M.
    Eur J Pharmacol; 2021 May 15; 899():174032. PubMed ID: 33753107
    [Abstract] [Full Text] [Related]

  • 4. SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging.
    Zarzuelo MJ, López-Sepúlveda R, Sánchez M, Romero M, Gómez-Guzmán M, Ungvary Z, Pérez-Vizcaíno F, Jiménez R, Duarte J.
    Biochem Pharmacol; 2013 May 01; 85(9):1288-96. PubMed ID: 23422569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of Haemeoxygenase-1 Directly Improves Endothelial Function in Isolated Aortas from Obese Rats through the Ampk-Pi3k/Akt-Enos Pathway.
    Han F, Guo Y, Xu L, Hou N, Han F, Sun X.
    Cell Physiol Biochem; 2015 May 01; 36(4):1480-90. PubMed ID: 26160485
    [Abstract] [Full Text] [Related]

  • 7. Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway.
    Han F, Zhang S, Hou N, Wang D, Sun X.
    Am J Physiol Heart Circ Physiol; 2015 Nov 01; 309(9):H1501-8. PubMed ID: 26371167
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of vascular PPAR-γ contributes to endothelial dysfunction in high-fat diet-induced obese mice exposed to chronic intermittent hypoxia.
    Zhang Y, Zhang C, Li H, Hou J.
    Biochem Biophys Res Commun; 2017 Oct 14; 492(2):243-248. PubMed ID: 28822761
    [Abstract] [Full Text] [Related]

  • 9. Alogliptin improves endothelial function by promoting autophagy in perivascular adipose tissue of obese mice through a GLP-1-dependent mechanism.
    Zhu B, Li Y, Mei W, He M, Ding Y, Meng B, Zhao H, Xiang G.
    Vascul Pharmacol; 2019 Apr 14; 115():55-63. PubMed ID: 30447331
    [Abstract] [Full Text] [Related]

  • 10. The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.
    Kumar DP, Caffrey R, Marioneaux J, Santhekadur PK, Bhat M, Alonso C, Koduru SV, Philip B, Jain MR, Giri SR, Bedossa P, Sanyal AJ.
    Sci Rep; 2020 Jun 09; 10(1):9330. PubMed ID: 32518275
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
    Makled MN, El-Kashef DH.
    Life Sci; 2020 Jul 15; 253():117729. PubMed ID: 32348836
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dietary polyphenol morin rescues endothelial dysfunction in a diabetic mouse model by activating the Akt/eNOS pathway.
    Taguchi K, Hida M, Hasegawa M, Matsumoto T, Kobayashi T.
    Mol Nutr Food Res; 2016 Mar 15; 60(3):580-8. PubMed ID: 26626705
    [Abstract] [Full Text] [Related]

  • 15. Saroglitazar, a novel dual PPAR-α/γ agonist, reverses high fat-low protein diet-induced metabolic and cognitive aberrations in C57BL/6J male mice.
    Dharavath RN, Arora S, Kondepudi KK, Bishnoi M, Chopra K.
    Life Sci; 2021 Apr 15; 271():119191. PubMed ID: 33571514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uncoupling of Endothelial Nitric Oxide Synthase in Perivascular Adipose Tissue of Diet-Induced Obese Mice.
    Xia N, Horke S, Habermeier A, Closs EI, Reifenberg G, Gericke A, Mikhed Y, Münzel T, Daiber A, Förstermann U, Li H.
    Arterioscler Thromb Vasc Biol; 2016 Jan 15; 36(1):78-85. PubMed ID: 26586660
    [Abstract] [Full Text] [Related]

  • 18. Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue.
    Kumar D, Goand UK, Gupta S, Shankar K, Varshney S, Rajan S, Srivastava A, Gupta A, Vishwakarma AL, Srivastava AK, Gaikwad AN.
    Eur J Pharmacol; 2018 Mar 05; 822():32-42. PubMed ID: 29331565
    [Abstract] [Full Text] [Related]

  • 19. New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
    Kaul U, Parmar D, Manjunath K, Shah M, Parmar K, Patil KP, Jaiswal A.
    Cardiovasc Diabetol; 2019 Jun 17; 18(1):80. PubMed ID: 31208414
    [Abstract] [Full Text] [Related]

  • 20. Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar.
    Jia WQ, Jing Z, Liu X, Feng XY, Liu YY, Wang SQ, Xu WR, Liu JW, Cheng XC.
    J Biomol Struct Dyn; 2018 Oct 17; 36(13):3496-3512. PubMed ID: 29081262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.